Robert Bell
Pediatrics · Beaumont, TXNPI 1396008280
Payments from drug & device makers
Across 3,719 payments — averaging $2510.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$5M
- Bavarian Nordic A/s$998K
- GSK$714K
- Novavax Inc$551K
- Pfizer$503K
- Valneva Austria GmbH$464K
- plus $1.1M from 25 others
Across 6 payments — averaging $16,361 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$98K
What the payments were for
- Travel & lodging$9,25087%
- Food & beverage$1,43913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2,978 | $5,005,602 |
| Bavarian Nordic A/s | 74 | $997,678 |
| GSK | 164 | $713,676 |
| Novavax Inc | 63 | $550,689 |
| Pfizer | 62 | $502,514 |
| Valneva Austria GmbH | 17 | $463,566 |
| Johnson & Johnson | 41 | $289,881 |
| Sanofi Pasteur Inc. | 58 | $277,270 |
| Janssen Research & Development, LLC | 9 | $211,841 |
| AbbVie | 64 | $136,626 |
| Takeda Pharmaceuticals U.S.A., Inc. | 61 | $55,939 |
| Sanofi US Services Inc. | 71 | $46,525 |
| Genentech, Inc. | 7 | $32,348 |
| Invivyd Inc | 3 | $23,628 |
| AstraZeneca | 2 | $18,359 |
| Hoffmann-la Roche Limited | 4 | $9,386 |
| Corium, LLC | 23 | $340 |
| Supernus Pharmaceuticals, Inc. | 5 | $107 |
| Organon | 1 | $28 |
| Shire North American Group Inc | 1 | $24 |
| LNHC, Inc | 1 | $22 |
| Tris Pharma Inc | 1 | $21 |
| Abbott | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
How this compares
$9,336,216 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Beaumont
- Ramona Ataya-DakourBeaumont$222K
- Kashif AliHouston$19.1M
- Clifford YutThe Woodlands$10.2M
- Ionela IacobasHouston$10.1M
- Khozema PalanpurwalaHouston$9.7M
- John ClintonPort Lavaca$8.6M
- Ronald BlairDallas$7.7M
- Wieslaw JakubowskiCorpus Christi$5M
- Martin YudovichHouston$4.4M
- Carlos BacinoHouston$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.